The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global In Vitro Gene Therapy Market Research Report 2024

Global In Vitro Gene Therapy Market Research Report 2024

Publishing Date : May, 2024

License Type :
 

Report Code : 2002190

No of Pages : 79

Synopsis
The global In Vitro Gene Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for In Vitro Gene Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for In Vitro Gene Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for In Vitro Gene Therapy in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of In Vitro Gene Therapy include Orchard Therapeutics, Kolon Pharma, bluebird bio, Novartis, GILD (Kite Pharma), Bristol Myers Squibb and JW Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for In Vitro Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Gene Therapy.
Report Scope
The In Vitro Gene Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Vitro Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Orchard Therapeutics
Kolon Pharma
bluebird bio
Novartis
GILD (Kite Pharma)
Bristol Myers Squibb
JW Therapeutics
Segment by Type
CAR-T
CRISPR
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Gene Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Gene Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CAR-T
1.2.3 CRISPR
1.3 Market by Application
1.3.1 Global In Vitro Gene Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Gene Therapy Market Perspective (2019-2030)
2.2 In Vitro Gene Therapy Growth Trends by Region
2.2.1 Global In Vitro Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In Vitro Gene Therapy Historic Market Size by Region (2019-2024)
2.2.3 In Vitro Gene Therapy Forecasted Market Size by Region (2025-2030)
2.3 In Vitro Gene Therapy Market Dynamics
2.3.1 In Vitro Gene Therapy Industry Trends
2.3.2 In Vitro Gene Therapy Market Drivers
2.3.3 In Vitro Gene Therapy Market Challenges
2.3.4 In Vitro Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Gene Therapy Players by Revenue
3.1.1 Global Top In Vitro Gene Therapy Players by Revenue (2019-2024)
3.1.2 Global In Vitro Gene Therapy Revenue Market Share by Players (2019-2024)
3.2 Global In Vitro Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro Gene Therapy Revenue
3.4 Global In Vitro Gene Therapy Market Concentration Ratio
3.4.1 Global In Vitro Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Gene Therapy Revenue in 2023
3.5 In Vitro Gene Therapy Key Players Head office and Area Served
3.6 Key Players In Vitro Gene Therapy Product Solution and Service
3.7 Date of Enter into In Vitro Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Gene Therapy Breakdown Data by Type
4.1 Global In Vitro Gene Therapy Historic Market Size by Type (2019-2024)
4.2 Global In Vitro Gene Therapy Forecasted Market Size by Type (2025-2030)
5 In Vitro Gene Therapy Breakdown Data by Application
5.1 Global In Vitro Gene Therapy Historic Market Size by Application (2019-2024)
5.2 Global In Vitro Gene Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In Vitro Gene Therapy Market Size (2019-2030)
6.2 North America In Vitro Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In Vitro Gene Therapy Market Size by Country (2019-2024)
6.4 North America In Vitro Gene Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Gene Therapy Market Size (2019-2030)
7.2 Europe In Vitro Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In Vitro Gene Therapy Market Size by Country (2019-2024)
7.4 Europe In Vitro Gene Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Gene Therapy Market Size (2019-2030)
8.2 Asia-Pacific In Vitro Gene Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In Vitro Gene Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific In Vitro Gene Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Gene Therapy Market Size (2019-2030)
9.2 Latin America In Vitro Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In Vitro Gene Therapy Market Size by Country (2019-2024)
9.4 Latin America In Vitro Gene Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Gene Therapy Market Size (2019-2030)
10.2 Middle East & Africa In Vitro Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In Vitro Gene Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa In Vitro Gene Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Orchard Therapeutics
11.1.1 Orchard Therapeutics Company Detail
11.1.2 Orchard Therapeutics Business Overview
11.1.3 Orchard Therapeutics In Vitro Gene Therapy Introduction
11.1.4 Orchard Therapeutics Revenue in In Vitro Gene Therapy Business (2019-2024)
11.1.5 Orchard Therapeutics Recent Development
11.2 Kolon Pharma
11.2.1 Kolon Pharma Company Detail
11.2.2 Kolon Pharma Business Overview
11.2.3 Kolon Pharma In Vitro Gene Therapy Introduction
11.2.4 Kolon Pharma Revenue in In Vitro Gene Therapy Business (2019-2024)
11.2.5 Kolon Pharma Recent Development
11.3 bluebird bio
11.3.1 bluebird bio Company Detail
11.3.2 bluebird bio Business Overview
11.3.3 bluebird bio In Vitro Gene Therapy Introduction
11.3.4 bluebird bio Revenue in In Vitro Gene Therapy Business (2019-2024)
11.3.5 bluebird bio Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis In Vitro Gene Therapy Introduction
11.4.4 Novartis Revenue in In Vitro Gene Therapy Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 GILD (Kite Pharma)
11.5.1 GILD (Kite Pharma) Company Detail
11.5.2 GILD (Kite Pharma) Business Overview
11.5.3 GILD (Kite Pharma) In Vitro Gene Therapy Introduction
11.5.4 GILD (Kite Pharma) Revenue in In Vitro Gene Therapy Business (2019-2024)
11.5.5 GILD (Kite Pharma) Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Detail
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb In Vitro Gene Therapy Introduction
11.6.4 Bristol Myers Squibb Revenue in In Vitro Gene Therapy Business (2019-2024)
11.6.5 Bristol Myers Squibb Recent Development
11.7 JW Therapeutics
11.7.1 JW Therapeutics Company Detail
11.7.2 JW Therapeutics Business Overview
11.7.3 JW Therapeutics In Vitro Gene Therapy Introduction
11.7.4 JW Therapeutics Revenue in In Vitro Gene Therapy Business (2019-2024)
11.7.5 JW Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global In Vitro Gene Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of CAR-T
Table 3. Key Players of CRISPR
Table 4. Global In Vitro Gene Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global In Vitro Gene Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global In Vitro Gene Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global In Vitro Gene Therapy Market Share by Region (2019-2024)
Table 8. Global In Vitro Gene Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global In Vitro Gene Therapy Market Share by Region (2025-2030)
Table 10. In Vitro Gene Therapy Market Trends
Table 11. In Vitro Gene Therapy Market Drivers
Table 12. In Vitro Gene Therapy Market Challenges
Table 13. In Vitro Gene Therapy Market Restraints
Table 14. Global In Vitro Gene Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global In Vitro Gene Therapy Market Share by Players (2019-2024)
Table 16. Global Top In Vitro Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Gene Therapy as of 2023)
Table 17. Ranking of Global Top In Vitro Gene Therapy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by In Vitro Gene Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In Vitro Gene Therapy Product Solution and Service
Table 21. Date of Enter into In Vitro Gene Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In Vitro Gene Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global In Vitro Gene Therapy Revenue Market Share by Type (2019-2024)
Table 25. Global In Vitro Gene Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global In Vitro Gene Therapy Revenue Market Share by Type (2025-2030)
Table 27. Global In Vitro Gene Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global In Vitro Gene Therapy Revenue Market Share by Application (2019-2024)
Table 29. Global In Vitro Gene Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global In Vitro Gene Therapy Revenue Market Share by Application (2025-2030)
Table 31. North America In Vitro Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America In Vitro Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America In Vitro Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe In Vitro Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe In Vitro Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe In Vitro Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific In Vitro Gene Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific In Vitro Gene Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific In Vitro Gene Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America In Vitro Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America In Vitro Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America In Vitro Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa In Vitro Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa In Vitro Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa In Vitro Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. Orchard Therapeutics Company Detail
Table 47. Orchard Therapeutics Business Overview
Table 48. Orchard Therapeutics In Vitro Gene Therapy Product
Table 49. Orchard Therapeutics Revenue in In Vitro Gene Therapy Business (2019-2024) & (US$ Million)
Table 50. Orchard Therapeutics Recent Development
Table 51. Kolon Pharma Company Detail
Table 52. Kolon Pharma Business Overview
Table 53. Kolon Pharma In Vitro Gene Therapy Product
Table 54. Kolon Pharma Revenue in In Vitro Gene Therapy Business (2019-2024) & (US$ Million)
Table 55. Kolon Pharma Recent Development
Table 56. bluebird bio Company Detail
Table 57. bluebird bio Business Overview
Table 58. bluebird bio In Vitro Gene Therapy Product
Table 59. bluebird bio Revenue in In Vitro Gene Therapy Business (2019-2024) & (US$ Million)
Table 60. bluebird bio Recent Development
Table 61. Novartis Company Detail
Table 62. Novartis Business Overview
Table 63. Novartis In Vitro Gene Therapy Product
Table 64. Novartis Revenue in In Vitro Gene Therapy Business (2019-2024) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. GILD (Kite Pharma) Company Detail
Table 67. GILD (Kite Pharma) Business Overview
Table 68. GILD (Kite Pharma) In Vitro Gene Therapy Product
Table 69. GILD (Kite Pharma) Revenue in In Vitro Gene Therapy Business (2019-2024) & (US$ Million)
Table 70. GILD (Kite Pharma) Recent Development
Table 71. Bristol Myers Squibb Company Detail
Table 72. Bristol Myers Squibb Business Overview
Table 73. Bristol Myers Squibb In Vitro Gene Therapy Product
Table 74. Bristol Myers Squibb Revenue in In Vitro Gene Therapy Business (2019-2024) & (US$ Million)
Table 75. Bristol Myers Squibb Recent Development
Table 76. JW Therapeutics Company Detail
Table 77. JW Therapeutics Business Overview
Table 78. JW Therapeutics In Vitro Gene Therapy Product
Table 79. JW Therapeutics Revenue in In Vitro Gene Therapy Business (2019-2024) & (US$ Million)
Table 80. JW Therapeutics Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In Vitro Gene Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global In Vitro Gene Therapy Market Share by Type: 2023 VS 2030
Figure 3. CAR-T Features
Figure 4. CRISPR Features
Figure 5. Global In Vitro Gene Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global In Vitro Gene Therapy Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Specialty Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. In Vitro Gene Therapy Report Years Considered
Figure 11. Global In Vitro Gene Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global In Vitro Gene Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global In Vitro Gene Therapy Market Share by Region: 2023 VS 2030
Figure 14. Global In Vitro Gene Therapy Market Share by Players in 2023
Figure 15. Global Top In Vitro Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Gene Therapy as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by In Vitro Gene Therapy Revenue in 2023
Figure 17. North America In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America In Vitro Gene Therapy Market Share by Country (2019-2030)
Figure 19. United States In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe In Vitro Gene Therapy Market Share by Country (2019-2030)
Figure 23. Germany In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific In Vitro Gene Therapy Market Share by Region (2019-2030)
Figure 31. China In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America In Vitro Gene Therapy Market Share by Country (2019-2030)
Figure 39. Mexico In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa In Vitro Gene Therapy Market Share by Country (2019-2030)
Figure 43. Turkey In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia In Vitro Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Orchard Therapeutics Revenue Growth Rate in In Vitro Gene Therapy Business (2019-2024)
Figure 46. Kolon Pharma Revenue Growth Rate in In Vitro Gene Therapy Business (2019-2024)
Figure 47. bluebird bio Revenue Growth Rate in In Vitro Gene Therapy Business (2019-2024)
Figure 48. Novartis Revenue Growth Rate in In Vitro Gene Therapy Business (2019-2024)
Figure 49. GILD (Kite Pharma) Revenue Growth Rate in In Vitro Gene Therapy Business (2019-2024)
Figure 50. Bristol Myers Squibb Revenue Growth Rate in In Vitro Gene Therapy Business (2019-2024)
Figure 51. JW Therapeutics Revenue Growth Rate in In Vitro Gene Therapy Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’